Zipsor FDA Approval History
FDA Approved: Yes (First approved June 16, 2009)
Brand name: Zipsor
Generic name: diclofenac potassium
Dosage form: Capsules
Company: Xanodyne Pharmaceuticals, Inc.
Treatment for: Pain
Zipsor is a rapid release diclofenac potassium formulation for the treatment of patients with mild to moderate acute pain.
Development Timeline for Zipsor
|Jun 17, 2009||ApprovalXanodyne Receives Approval From the U.S. Food and Drug Administration for Zipsor (diclofenac potassium) Liquid Filled Capsules|
|Jul 22, 2008||Xanodyne Receives Approvable Letter From the FDA for Zipsor Capsules|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.